Elgi Equipments Ltd. — Board/Management Information 2024

Mar 15, 2024

==> picture [112 x 37] intentionally omitted <==

National Stock Exchange of lndia Ltd. Exchange Plaza, C-1, Block G Bandra Kurla Complex Bandra (E) Mumbai - 400 051

BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai - 400 001

Through : NEAPS

Through : BSE Listing Centre

Dear Sir/Madam,

Subject: Intimation under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. NSE Scrip Code: ELGIEQUIP / BSE Scrip Code: 522074

Mr. Jayakanthan R, as Chief Financial Officer of the Company with effect from March 18, 2024, and that he will continue to serve on the rolls of the Company in the position of Senior Managerial Personnel until May 31, 2024, on which date he will superannuate from the Company.

The Board had found a successor for the position of Chief Financial Officer and in its meeting held today appointed Mr. Indranil Sen as the Chief Financial Officer and Key Managerial Personnel of the Company with effect from March 18, 2024. A brief profile of Mr. Indranil Sen in enclosed as Annexure B.

We are enclosing herewith the brief details of the aforesaid changes as prescribed under SEBI Listing Regulations read with SEBI circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, as Annexure A .

Kindly take the above information on record and acknowledge.

Thanking you,

Yours Faithfully,

For Elgi Equipments Limited

Digitally signed PULLA by PULLA MOTHILAL MOTHILAL VAISHNAVI VAISHNAVI Date: 2024.03.15 11:41:16 +05'30'

Vaishnavi PM

Compliance Officer

==> picture [414 x 44] intentionally omitted <==

==> picture [112 x 37] intentionally omitted <==

Annexure A

Details as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with clause 7 of the SEBI circular dated 9th September, 2015.

2015.
S. No.	Particulars	Details
1	Name	Mr. Jayakanthan R	Mr. Indranil sen
2	Reason for chang viz. appointment, resignation, removal, death, cessation or otherwise	e Relinquishment as Chief Financial Officer of the Company with effect from March 18, 2024	Appointment as Chief Financial Officer and Key Managerial Personnel of the Company with effect from March 18, 2024.
3	Date of appointment /cessation (as applicable) & term of appointment	The Board of Directors in their meeting held today took note of relinquishment of Mr. Jayakanthan R as Chief Financial Officer of the Company with effect from March 18, 2024, and that he will continue to serve on the rolls of the Company in the position of Senior Managerial Personnel until May 31, 2024, on which date he will superannuate from the Company.	The Board of Directors in their meeting held today, based on the recommendation of the Nomination and Remuneration Committee and the Audit Committee considered and approved the appointment of Mr. Indranil Sen as Chief Financial Officer and Key Managerial Personnel of the Company with effect from March 18, 2024.
4	Brief Profile	Not Applicable	Attached as Annexure B
5	Disclosure of Relationships between Directors	Not Applicable	Not Applicable

==> picture [414 x 44] intentionally omitted <==

==> picture [112 x 37] intentionally omitted <==

Annexure B

Brief profile of Mr. Indranil Sen

Indranil is a seasoned finance leader with years of rich experience across audit firms, IT, and pharmaceuticals. He was last associated with Biocon Ltd.

He started his career in the Big 4 and his previous stints with Symphony Teleca Corporation, E&Y, KPMG & Price Waterhouse have

==> picture [105 x 106] intentionally omitted <==

given him exposure to different business models, working styles, and cultures, something that makes him very adaptable, working with clients across sector, handling complex accounting issues.

He has worked extensively on top line (partnership, in licensing and out licensing) and bottomline growth, with a lot of focus on bottom line given the nature of business.

Indranil's first move after a long audit stint was to Symphony, an IT service firm. He was a core part of the finance team, helping integrate technology into the finance function, and improve processes.

At Biocon he started his stint focused on controllership and taxation before changing gears to focus on business finance, finally growing into the CFO role. Fairly early on, he made the switch from being a finance leader to a business partner, developing a long-term strategic point of view on business.

Indranil manages diverse stakeholders with an appropriate alignment of interests. He has been able to build relationships with private equity players, industry analysts, regulators, and his board to positively impact the organization's standing in their view.

==> picture [414 x 44] intentionally omitted <==